QM/MM based 3D QSAR models for potent B-Raf inhibitors
暂无分享,去创建一个
Jae Yoon Chung | Seung Joo Cho | Hwan Won Chung | Art E. Cho | Jung-Mi Hah | S. Cho | J. Hah | A. Cho | J. Chung | H. W. Chung
[1] Richard A. Friesner,et al. Mixed ab initio QM/MM modeling using frozen orbitals and tests with alanine dipeptide and tetrapeptide , 1999 .
[2] Maulik R. Patel,et al. CoMFA and CoMSIA Studies on 1, 3-Bis(benzylidene)-3, 4-dihydro-1H-naphthalen-2-one, 2, 6-Bis(benzylidene)cyclohexanone, and 3, 5-Bis(benzylidene)-4-piperidone Series of Cytotoxic Compounds , 2007, J. Chem. Inf. Model..
[3] Igor V. Tetko,et al. Prediction of n-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices , 2001, J. Chem. Inf. Comput. Sci..
[4] X. F. Zhang,et al. Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. , 2001, Recent progress in hormone research.
[5] Meenhard Herlyn,et al. BRAF as a potential therapeutic target in melanoma and other malignancies. , 2003, Cancer cell.
[6] Mike Welch,et al. Potent and selective pyrazole-based inhibitors of B-Raf kinase. , 2008, Bioorganic & medicinal chemistry letters.
[7] Richard Marais,et al. The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.
[8] J. Buolamwini,et al. CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site. , 2002, Journal of medicinal chemistry.
[9] U. Rapp,et al. Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma. , 2008, The Journal of investigative dermatology.
[10] L. Johnson,et al. Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.
[11] Victor Guallar,et al. Importance of accurate charges in molecular docking: Quantum mechanical/molecular mechanical (QM/MM) approach , 2005, J. Comput. Chem..
[12] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[13] Anders Berglund,et al. PCA and PLS with very large data sets , 2005, Comput. Stat. Data Anal..
[14] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[15] K. Zheng,et al. CoMFA and docking studies of 2-phenylindole derivatives with anticancer activity. , 2009, European journal of medicinal chemistry.
[16] Yong-Jun Jiang,et al. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. , 2009, European journal of medicinal chemistry.
[17] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[18] Gerhard Klebe,et al. Comparative Molecular Similarity Index Analysis (CoMSIA) to study hydrogen-bonding properties and to score combinatorial libraries , 1999, J. Comput. Aided Mol. Des..
[19] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.